PRESENTATION OBJECTIVES

At the conclusion of this presentation, attendees will be able to:

1) Define and discuss molecular mechanisms of water transport.

2) Discuss the role of Aquaporin-4 (AQP4) in cerebral edema formation.

3) Discuss the role of Aquaporin-1 (AQP1) in cerebrospinal fluid production and intracranial pressure.

4) Describe the therapeutic potential of AQP inhibitors in the treatment of brain and spinal cord injury.